Bridgeway Capital Management, LLC In8 Bio, Inc. Transaction History
Bridgeway Capital Management, LLC
- $4.14 Billion
- Q2 2024
A detailed history of Bridgeway Capital Management, LLC transactions in In8 Bio, Inc. stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 103,302 shares of INAB stock, worth $29,957. This represents 0.0% of its overall portfolio holdings.
Number of Shares
103,302
Previous 103,302
-0.0%
Holding current value
$29,957
Previous $121,000
28.1%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding INAB
# of Institutions
27Shares Held
7.74MCall Options Held
0Put Options Held
0-
Aigh Capital Management LLC Baltimore, MD2.13MShares$617,1190.66% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.42MShares$412,9300.0% of portfolio
-
Ensign Peak Advisors, Inc Salt Lake City, UT1.12MShares$324,2970.0% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL641KShares$185,8920.0% of portfolio
-
Sigma Planning Corp Ann Arbor, MI600KShares$173,9070.02% of portfolio
About IN8BIO, INC.
- Ticker INAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,502,200
- Market Cap $7.11M
- Description
- IN8bio, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of gamma-delta T cell therapies for the treatment of cancers. Its lead product candidate includes INB-200, a genetically modified autologous gamma-delta T cell product candidate that is in Phase I clinical trial for the treatment of...